Table 2. Summary of questionnaire compliance at each assessment point.

Assessment point	No. of patients (%)
	Non-HIPEC (valid/expected)	HIPEC (valid/expected)
Patients enrolled	92	92
Before randomization	82/92 (89.1)	83/92 (90.2)
POD 7	81/82 (98.8)	75/83 (90.4)
After 3 cycles of adjuvant chemotherapy	62/74 (83.8)	68/76 (89.5)
After 6 cycles of adjuvant chemotherapy	51/64 (79.7)	61/69 (88.4)
3 mon after treatment	50/60 (83.3)	54/66 (81.8)
6 mon after treatment	41/51 (80.4)	46/54 (85.2)
9 mon after treatment	38/47 (80.9)	37/48 (75.5)
12 mon after treatment	34/38 (89.5)	34/42 (81.0)

HIPEC, hyperthermic intraperitoneal chemotherapy; POD, postoperative day.